Physician profile
Ryan R Stratford
NPI 1689668493
$6,412.98
in general payments reported to CMS, 2019-2025
26 companies · $772 in 2025
The $772 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,793 · 2020: $2,450 · 2021: $314 · 2022: $395 · 2023: $411 · 2024: $277 · 2025: $772.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,459.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,459.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Caldera Medical, INC | $3,925.05 | 2019-2023 | Desara |
| Medtronic, INC. | $410.55 | 2021-2025 | Altaviva, Interstim, Truclear |
| Abbvie INC. | $361.91 | 2019-2025 | Botox |
| Femselect INC. | $188.81 | 2025 | Enplace |
| Smith+Nephew, INC. | $181.54 | 2021-2023 | Stravix |
| 180 Medical, INC. | $172.78 | 2019-2025 | Gentlecath Glide, Gentlecath |
| Boston Scientific Corporation | $168.32 | 2019-2024 | Advantage System, Upsylon |
| Pfizer INC. | $142.95 | 2019-2022 | |
| Therapeuticsmd, INC. | $142.28 | 2019-2021 | |
| Axonics, INC. | $122.90 | 2021-2023 | Axonics |
| Sumitomo Pharma America, INC. | $111.09 | 2023-2025 | Gemtesa |
| Astellas Pharma US INC | $86.67 | 2021-2023 | Veozah |
| Coloplast Corp | $61.11 | 2019-2025 | Saffron |
| Allergan, INC. | $50.46 | 2020-2021 | |
| Hollister Incorporated | $49.23 | 2021-2023 | Onli, Vapro Pocket, Infyna Chic |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $28.88 | 2021-2024 | Enseal X1 |
| Pharmacosmos Therapeutics INC. | $28.46 | 2022 | |
| Applied Medical Resources Corporation | $24.00 | 2023 | |
| Medtronic USA, INC. | $23.17 | 2020 | |
| Laborie Medical Technologies Corp. | $20.77 | 2025 | |
| Baxter Healthcare | $20.03 | 2020 | |
| Urovant Sciences INC | $19.68 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $19.52 | 2022 | |
| Intuitive Surgical, INC. | $17.98 | 2022 | |
| Millicent US INC | $17.82 | 2023 | Intrarosa, Femring |
| Urocure LLC | $17.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Stratford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.